ST
CLVS

Spot Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Spot Trading’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-6,426
Closed -$93.9K – 3937
2016
Q1 		$123K Buy
+6,426
New +$136K ﹤0.01% 2477
2015
Q4 		– Sell
-1,645
Closed -$151K – 4199
2015
Q3 		$151K Sell
1,645
-2,128
-56% -$184K ﹤0.01% 2854
2015
Q2 		$332K Buy
3,773
+3,718
+6,760% +$318K ﹤0.01% 2387
2015
Q1 		$4K Buy
+55
New +$3.88K ﹤0.01% 3683
2014
Q2 		– Sell
-3,233
Closed -$167K – 4907
2014
Q1 		$224K Buy
+3,233
New +$237K ﹤0.01% 3073
2013
Q4 		– Sell
-5,473
Closed -$333K – 4403
2013
Q3 		$333K Buy
+5,473
New +$388K ﹤0.01% 2697

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Spot Trading's CLVS Position: Q2 2016 in Review

Spot Trading sold out of Clovis Oncology, Inc. (CLVS) in Q2 2016, closing a stake of 6,426 shares — an estimated $93.9K sold.

Spot Trading first reported a position in CLVS in Q3 2013 and held it in 6 quarters. The position peaked at $333K in Q3 2013. 122 funds tracked by Wall St. Rank hold CLVS as of Q2 2016.

  • Spot Trading reported no remaining Clovis Oncology, Inc. position as of Q2 2016 after selling out during the quarter.
  • Spot Trading sold 6,426 Clovis Oncology, Inc. shares in Q2 2016, an estimated $93.9K.
  • Spot Trading first reported a position in Clovis Oncology, Inc. in Q3 2013 and held it in 6 quarters.
  • Spot Trading's Clovis Oncology, Inc. position peaked at $333K in Q3 2013.
  • 122 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2016.

Based on Spot Trading's 13F filing for Q2 2016, filed 2 Aug 2016.